Literature DB >> 24284513

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward.

Adeera Levin1, Paul E Stevens2.   

Abstract

The 2012 KDIGO Guideline for CKD evaluation, classification, and management has updated the original 2002 KDOQI Guidelines, using newer data and addressing issues raised over the last decade concerning definitions and assessment. This review highlights the key aspects of the CKD guideline, and describes the rationale for specific wording and the scope of the document. A précis of key concepts in each of the five sections of the guideline is presented. The guideline document is intended for general practitioners and nephrologists, and covers CKD evaluation, classification, and management for both adults and children. Throughout the guideline, we have attempted to overtly address areas of controversy or non-consensus, international relevance, and impact on practice and public policy.

Entities:  

Mesh:

Year:  2013        PMID: 24284513     DOI: 10.1038/ki.2013.444

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  210 in total

1.  Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation.

Authors:  Matti Peperhove; Van Dai Vo Chieu; Mi-Sun Jang; Marcel Gutberlet; Dagmar Hartung; Susanne Tewes; Gregor Warnecke; Christiane Fegbeutel; Axel Haverich; Wilfried Gwinner; Frank Lehner; Jan Hinrich Bräsen; Hermann Haller; Frank Wacker; Faikah Gueler; Katja Hueper
Journal:  Eur Radiol       Date:  2017-07-14       Impact factor: 5.315

2.  Clinical characteristics of biopsy-proven renal sarcoidosis in Japan.

Authors:  Yoshinori Kamata; Hiroshi Sato; Kensuke Joh; Yoshinori Tsuchiya; Shinobu Kunugi; Akira Shimizu; Tsuneo Konta; Robert P Baughman; Arata Azuma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fatima Hassan; Fridtjof Thomas; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Kidney Int       Date:  2018-03-02       Impact factor: 10.612

4.  Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.

Authors:  Giuseppe Cullaro; Joseph F Pisa; Robert S Brown; Gebhard Wagener; Elizabeth C Verna
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

5.  Exercise to improve physical function and quality of life in CKD.

Authors:  Manisha Jhamb; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

6.  Sleep Duration and Health-Related Quality of Life in Predialysis CKD.

Authors:  Su-Ah Sung; Young Youl Hyun; Kyu Beck Lee; Hayne Cho Park; Wookyung Chung; Yeong Hoon Kim; Yong-Soo Kim; Sue Kyung Park; Kook-Hwan Oh; Curie Ahn
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 8.237

Review 7.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

8.  Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects.

Authors:  Akiko Toda; Shigeko Hara; Hiroshi Tsuji; Yasuji Arase
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

9.  Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis.

Authors:  Marko Lucijanic; Davor Galusic; Ivan Krecak; Martina Sedinic; Hrvoje Holik; Vlatka Perisa; Martina Moric Peric; Ivan Zekanovic; Tajana Stoos-Veic; Rajko Kusec
Journal:  Ann Hematol       Date:  2020-08-29       Impact factor: 3.673

Review 10.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.